Athens Research/Cambio - Excellence in Molecular Biology/0.25g/10-1028-02

价格
面议
货号:10-1028-02
浏览量:127
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen"sproductsarehazardousandmay be subject to additional shipping charges. Full product information is available onGlen Research"s website.

  • Catalogue
  • Description
  • Protocols
  • Notes
  • Applications & Benefits

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
10-1028-028-oxo-dG-CE Phosphoramidite0.25g£780.00£741.00Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1028-908-oxo-dG-CE Phosphoramidite100µmoles£284.00£269.80Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order
10-1028-958-oxo-dG-CE Phosphoramidite50µmoles£142.00£134.90Offer until : 31-Mar-2021Offer Code : GLEN55% off all Glen productsView OfferQuantityAdd to Order

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

8-oxo-dG-CE Phosphoramidite

Structure

Catalog Number: 10-1028-xx

Description: 8-oxo-dG-CE Phosphoramidite

5"-Dimethoxytrityl-N2-isobutyryl-8-oxo-deoxyGuanosine-3"-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
Formula: C44H54N7O9PM.W.: 855.93F.W.: 345.21

Diluent: Anhydrous Acetonitrile
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.
Deprotection: Cleave and deprotect with ammonium hydroxide containing 0.25M 2-mercaptoethanol 17 hours at 55°C to avoid oxidative degradation of the 8-oxo-dG site.
Storage: Refrigerated storage, maximum of 2-8°C, dry

Stability in Solution: 24 hours

DNA Damage/Repair

Cellular DNA is constantly being damaged by oxidation andalkylation, by free radicals, and by ultraviolet and ionizing radiation. Thebody has therefore evolved a number of repair enzyme systems to excise andrepair these lesions. The 8-oxo purine monomers allow investigation of thestructure and activity of oligonucleotides containing an 8-oxo mutation which isformed naturally when DNA is subjected to oxidative conditions or ionizingradiation. 5,6-Dihydro pyrimidines are naturally occurring compounds that arestructural components of alanine transfer RNA. Dihydrouracil and the hydroxypyrimidines are major base damage products formed by exposure of DNA to ionizingradiation.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

MSDS

Glen Report 7.1: NEW MINOR BASES

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

Synthetic oligonucleotides containing 8-oxo-dG must be cleaved and deprotected with ammonium hydroxide containing 0.25M 2-mercaptoethanol to avoid oxidative degradation of 8-oxo-dG sites.

Frequently Asked Technical Question

QUESTION: How do you deprotect 8-oxo-dG?

RESPONSE:Cleave and deprotect with ammonium hydroxide containing 0.25M 2-mercaptoethanol 17 hours at 55°C to avoid oxidative degradation of the 8-oxo-dG site

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

8-oxo-dG-CE Phosphoramidite

8-oxo-dG-CE Phosphoramidite

Glen Research

EXTINCTION DATA

ItemNucleosideλMax-1Emax-1λMax-2Emax-2E260
(nm)(ml/µmole)nm(ml/µmole)(ml/µmole)
10-10288-oxo-dG2945.22506.75.9

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No.PackSizeGrams/Pack0.1M Dil.(mL)LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1028-020.25grams.25grams2.928450.431.522.9116.84.2
10-1028-90100µmoles.086grams120127.55.4541
10-1028-9550µmoles.043grams.53.3321.25.91.67.17
Expedite
Cat.No.PackSizeGrams/PackDilution(mL)Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1028-020.25grams.25grams4.36.0780.850.536.735.05
10-1028-90100µmoles.086grams1.5.0723.614.7510.731.48
10-1028-9550µmoles.043grams.75.078.65.383.91.54
Beckman
Cat.No.PackSizeGrams/PackDilution(mL)Molarity30nm200nm1000nm
Approximate Number of Additions
10-1028-020.25grams.25grams4.36.0782.451.537.45
10-1028-90100µmoles.086grams1.5.0725.215.7511.45
10-1028-9550µmoles.043grams.75.0710.26.384.64

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Athens Research & Technology 公司位于美国乔治亚州雅典市,从1986年以来一直致力于纯化高纯度,高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白,血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来,世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。 我们提供优质,可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务,Athens Research & Technology 公司能够根据您的项目要求提供无与伦比的试剂。